Moreover, randomized controlled trials found a 3.72-fold increase in risk of CRC in obese individuals with the MLH1 variant but no increase in risk in their counterparts taking aspirin 600 mg/day or those with MSH2 or MSH6 variants [342, 343]. This evidence concerns the gene MSH2 and colorectal carcinoma.